| Species | Original | Mutated to | Mutation |
| Human | Tyr 68 |
|
|
| Rat Equivalent | Tyr 73 | ||
| Mouse Equivalent | Tyr 73 | Ala |
Eleven residues (Tyr 50, Tyr 73, Tyr 88, Tyr 91, Tyr 94, Tyr 141, Tyr 143, Tyr 153, Tyr 167, Tyr 234, Tyr 240) were mutated individually for alanine, serine and some residues for phenylalanine. The ligands [3H]granisetron and 5-HT were used to examine the properities of ligand binding sites and function of the 5-HT3A receptor, respectively.
Mouse 5-HT3A receptors were expressed in Xenopus Oocytes (cRNA injection) and studied using two-electrode voltage-clamp technique. HEK293 cells were used in radioligand binding and calcium imaging assays to study the affinity of [3H]granisetron and the potency of 5-HT, respectively.
TheY73A and Y73S mutations did not significantly altered the affinity of the antagonist [3H]granisetron.
| Receptor | [3H]granisetron binding (Kd) | Cell membrane | Calcium imaging (EC50) mM | Electrophysiology (EC50) mM |
| WT | YES | ++ | 1.47 +/-0.42 | 2.39 +/- 0.23 |
| Y50F | NB | - | NR | NR |
| Y50A | NB | -/+ | NR | NR |
| Y50S | NB | -/+ | NR | 1.59 +/- 0.18 |
| Y73A/S | YES | NT | NT | NT |
| Y88A/S | YES | NT | NT | NT |
| Y91F | YES | NT | 2.13 +/- 0.51 | 4.22 +/-0.25 |
| Y91A | NB | - | NR | 13.7 +/-1.25* |
| Y91S | NB | + | NR | 57.7 +/-7.16 * |
| Y94A/S | YES | NT | NT | NT |
| Y141F | YES | NT | NT | NT |
| Y141A | YES | NT | NR | NT |
| Y141S | NB | ++ | NR | NT |
| Y143F | YES | NT | NT | NT |
| Y143A | YES | NT | NR | NT |
| Y143S | YES | NT | >500* | NT |
| Y153A | YES | NT | 74.3 +/- 8.9* | NT |
| Y153S | NB | ++ | 59.2 +/- 7.3* | NT |
| Y167A/S | YES | NT | NT | NT |
| Y234F | YES | NT | NT | NT |
| Y234A | NB | ++ | NR | NT |
| Y234S | NB | + | NR | NT |
| Y240A/S | YES | NT | NT | NT |
NT, Not tested; NB, No binding.
++, Presence of cell surface receptors revealed by immunocytochemistry
-/+, Reduced cell surface receptor expression compared to WT 5-HT3A
-, Absence of cell surface receptors
* significantly different from the WT 5-HT3A receptor
Twenty six residues (I71, Y73,W90, R92, N128, E129, Y143, Y153, T179, T181, S182,W183, L184, W195, V201, R202, S203, S206, I207, F226, I228, D229, I230, Y234, E236, K238) were replaced by either alanine or a residue with similar physicochemical properties to the native residue, to examine their roles in docking of [3H]granisetron into the 5-HT3A receptor binding site. Mouse 5-HT3A receptors were expressed in HEK293 cells and homology modeling, ligand-docking and radioligand binding were used.
The Y73A and Y73S mutations did not significantly altered the affinity of the antagonist [3H]granisetron. The table below lists conservative and non-conservative substitutions that either both, or individually affected [3H]granisetron binding.
| Receptor | [3H]granisetron binding (Kd) |
| WT | 0.31+/-0.04 |
| W90A* | NB |
| W90Y* | 0.90 +/- 0.06 |
| R92A* | 1.80 +/- 0.40 |
| R92K | 1.00 +/- 0.30 |
| E129A* | NB |
| E129D* | NB |
| Y153A* | 2.36 +/- 0.53 |
| Y153F | 0.90 +/- 0.20 |
| T179A* | 3.20 +/- 0.10 |
| T179S | 0.38 +/- 0.20 |
| S181A* | 0.12 +/- 0.04 |
| S181S | 0.58 +/- 0.10 |
| S182A* | 1.00 +/- 0.20 |
| S182T* | 1.80 +/- 0.09 |
| W183A*/Y* | NB |
| L184A* | 4.11 +/- 0.94 |
| L184I* | 0.71 +/- 0.05 |
| W195A* | 5.08 +/- 0.88 |
| W195Y* | 8.70 +/- 2.40 |
| S203A* | 0.08 +/-0.02 |
| S203T | 0.26 +/- 0.11 |
| S206A* | 1.67 +/- 0.27 |
| S206T* | 4.40 +/- 0.49 |
| I228A* | 1.40 +/- 0.30 |
| I228N | 0.30 +/- 0.05 |
| D229A* | 3.80 +/- 0.26 |
| D229E* | 0.11 +/- 0.03 |
| I230A | 0.30 +/- 0.10 |
| I230N* | 1.70 +/- 0.40 |
| Y234A* | NB |
| Y234F | 1.30 +/- 0.36 |
NB, No binding
* significantly different from the WT 5-HT3A receptor
Eleven residues (Tyr 50, Tyr 73, Tyr 88, Tyr 91, Tyr 94, Tyr 141, Tyr 143, Tyr 153, Tyr 167, Tyr 234, Tyr 240) were mutated individually for alanine, serine and some residues for phenylalanine. The ligands [3H]granisetron and 5-HT were used to examine the properities of ligand binding sites and function of the 5-HT3A receptor, respectively.
Mouse 5-HT3A receptors were expressed in Xenopus Oocytes (cRNA injection) and studied using two-electrode voltage-clamp technique. HEK293 cells were used in radioligand binding and calcium imaging assays to study the affinity of [3H]granisetron and the potency of 5-HT, respectively.
TheY73A and Y73S mutations did not significantly altered the affinity of the antagonist [3H]granisetron.
| Receptor | [3H]granisetron binding (Kd) | Cell membrane | Calcium imaging (EC50) mM | Electrophysiology (EC50) mM |
| WT | YES | ++ | 1.47 +/-0.42 | 2.39 +/- 0.23 |
| Y50F | NB | - | NR | NR |
| Y50A | NB | -/+ | NR | NR |
| Y50S | NB | -/+ | NR | 1.59 +/- 0.18 |
| Y73A/S | YES | NT | NT | NT |
| Y88A/S | YES | NT | NT | NT |
| Y91F | YES | NT | 2.13 +/- 0.51 | 4.22 +/-0.25 |
| Y91A | NB | - | NR | 13.7 +/-1.25* |
| Y91S | NB | + | NR | 57.7 +/-7.16 * |
| Y94A/S | YES | NT | NT | NT |
| Y141F | YES | NT | NT | NT |
| Y141A | YES | NT | NR | NT |
| Y141S | NB | ++ | NR | NT |
| Y143F | YES | NT | NT | NT |
| Y143A | YES | NT | NR | NT |
| Y143S | YES | NT | >500* | NT |
| Y153A | YES | NT | 74.3 +/- 8.9* | NT |
| Y153S | NB | ++ | 59.2 +/- 7.3* | NT |
| Y167A/S | YES | NT | NT | NT |
| Y234F | YES | NT | NT | NT |
| Y234A | NB | ++ | NR | NT |
| Y234S | NB | + | NR | NT |
| Y240A/S | YES | NT | NT | NT |
NT, Not tested; NB, Not binding
++, Presence of cell surface receptors revealed by immunocytochemistry
-/+, Reduced cell surface receptor expression compared to WT 5-HT3A
-, Absence of cell surface receptors
* significantly different from the WT 5-HT3A receptor
Twenty six residues (I71, Y73,W90, R92, N128, E129, Y143, Y153, T179, T181, S182,W183, L184, W195, V201, R202, S203, S206, I207, F226, I228, D229, I230, Y234, E236, K238) were replaced by either alanine or a residue with similar physicochemical properties to the native residue, to examine their roles in docking of [3H]granisetron into the 5-HT3A receptor binding site. Mouse 5-HT3A receptors were expressed in HEK293 cells and homology modeling, ligand-docking and radioligand binding were used.
The Y73A and Y73S mutations did not significantly altered the affinity of the antagonist [3H]granisetron. The table below lists conservative and non-conservative substitutions that either both, or individually affected [3H]granisetron binding.
| Receptor | [3H]granisetron binding (Kd) |
| WT | 0.31+/-0.04 |
| W90A* | NB |
| W90Y* | 0.90 +/- 0.06 |
| R92A* | 1.80 +/- 0.40 |
| R92K | 1.00 +/- 0.30 |
| E129A* | NB |
| E129D* | NB |
| Y153A* | 2.36 +/- 0.53 |
| Y153F | 0.90 +/- 0.20 |
| T179A* | 3.20 +/- 0.10 |
| T179S | 0.38 +/- 0.20 |
| S181A* | 0.12 +/- 0.04 |
| S181S | 0.58 +/- 0.10 |
| S182A* | 1.00 +/- 0.20 |
| S182T* | 1.80 +/- 0.09 |
| W183A*/Y* | NB |
| L184A* | 4.11 +/- 0.94 |
| L184I* | 0.71 +/- 0.05 |
| W195A* | 5.08 +/- 0.88 |
| W195Y* | 8.70 +/- 2.40 |
| S203A* | 0.08 +/-0.02 |
| S203T | 0.26 +/- 0.11 |
| S206A* | 1.67 +/- 0.27 |
| S206T* | 4.40 +/- 0.49 |
| I228A* | 1.40 +/- 0.30 |
| I228N | 0.30 +/- 0.05 |
| D229A* | 3.80 +/- 0.26 |
| D229E* | 0.11 +/- 0.03 |
| I230A | 0.30 +/- 0.10 |
| I230N* | 1.70 +/- 0.40 |
| Y234A* | NB |
| Y234F | 1.30 +/- 0.36 |
NB, No binding
* significantly different from the WT 5-HT3A receptor